Johnson & Johnson Vision Survey Highlights Barriers Faced by Women in Ophthalmology

Johnson & Johnson Vision Survey Highlights Barriers Faced by Women in Ophthalmology

Initial findings from a survey conducted by Ipsos to be revealed at the American Academy of Ophthalmology 2023 Annual Conference.

IRVINE, CA, October 23, 2023 – To coincide with Global Diversity Awareness Month, Johnson & Johnson Vision*, a global leader in eye health and part of Johnson & Johnson MedTech**, released key findings from the Women in Ophthalmology survey, uncovering barriers faced by female ophthalmologists. In the survey of more than 100 female ophthalmologists, two-thirds (66%) say their professional ophthalmology experience would be better if they received mentorship from other ophthalmologists of the same gender, yet only 26% received mentorship.

Other key highlights covered in the survey include:

  • More than half (56%) of female ophthalmologists surveyed say they aspire to mentor new ophthalmologists as they advance in their careers.
  • Over one-third (36%) of female ophthalmologists surveyed agree that there is a glass ceiling preventing them from reaching their career aspirations as an ophthalmologist.

“Results from the Women in Ophthalmology Survey highlight the inequities disproportionately faced by women ophthalmologists today which is unacceptable,” said Lori Tierney, President, Americas, Johnson & Johnson Vision. “At Johnson & Johnson Vision we are deeply committed to making ophthalmology a more diverse, equitable and inclusive environment and hope to ignite action to break down the barriers women face to ensure they can thrive in their quest to improve sight for patients.”

Further findings from the survey will be discussed during a panel discussion hosted by the Johnson & Johnson MedTech’s Vision team at the American Academy of Ophthalmology 2023 Annual Conference on Saturday, November 4th from 3:00pm – 3:50pm PDT. The panel, titled Women Leaders in Ophthalmology: Breaking Barriers, will discuss the need for greater diversity, inclusion and belonging among women in ophthalmology, including the critical need for mentorship in the field. The panel will feature industry leaders Lisa Nijm, MD, JD, Warrenville Eyecare and LASIK; and Sonia Yoo, MD, University of Miami Health Center; and Zaina Al-Mohtaseb, MD, Baylor College of Medicine. Find more information about this event, here: https://jnjvisionaao2023.com/

Johnson & Johnson is committed to advancing Diversity Equity and Inclusion (DEI) and will keep supporting leadership and mentorship programs to address the career aspirations of female ophthalmologists.

About Johnson & Johnson Vision*

Media contact:

Maria Jose Echeverria
Johnson & Johnson Vision
mechever@its.jnj.com

At Johnson & Johnson Vision*, part of Johnson & Johnson MedTech**, we have a bold ambition: to change the trajectory of eye health around the world. Through our operating companies, we deliver innovation that enables eye care professionals to create better outcomes for patients throughout their lives, with products and technologies that address unmet needs including refractive error, cataracts and dry eye. In communities with greatest need, we work in collaboration to expand access to quality eye care, and we are committed to helping people see better, connect better and live better. Visit us at www.jjvision.com. Follow @JNJVision on Twitter and Johnson & Johnson Vision on LinkedIn, and @JNJVision on Facebook.

About Johnson & Johnson MedTech**

At Johnson & Johnson MedTech, we unleash diverse healthcare expertise, purposeful technology, and a passion for people to transform the future of medical intervention and empower everyone to live their best life possible. For more than a century, we have driven breakthrough scientific innovation to address unmet needs and reimagine health. In surgery, orthopedics, vision, and interventional solutions, we continue to help save lives and create a future where healthcare solutions are smarter, less invasive, and more personalized.

About the Study

These are some of the findings of an Ipsos survey conducted between July 20-August 31, 2023 on behalf of Johnson & Johnson MedTech. For this survey, a sample of 100 female ophthalmologists, ages 18+ from the continental U.S., Alaska, and Hawaii was interviewed online in English. All sample surveys and polls may be subject to other sources of error, including, but not limited to coverage error, and measurement error.